| Literature DB >> 33297858 |
Vanessa L Schumacher1, Famke Aeffner2, Erio Barale-Thomas3, Catherine Botteron4, Jonathan Carter5, Laëtitia Elies6,7, Jeffery A Engelhardt8, Pierluigi Fant7, Thomas Forest9, Peter Hall10, Deon Hildebrand11, Robert Klopfleisch12, Thomas Lucotte13, Heike Marxfeld14, LuAnn Mckinney15, Pierre Moulin16, Elizabeth Neyens17, Xavier Palazzi18, Alain Piton19, Elena Riccardi20, Daniel R Roth21, Serge Rousselle22, Justin D Vidal23, Bethany Williams24,25.
Abstract
With advancements in whole slide imaging technology and improved understanding of the features of pathologist workstations required for digital slide evaluation, many institutions are investigating broad digital pathology adoption. The benefits of digital pathology evaluation include remote access to study or diagnostic case materials and integration of analysis and reporting tools. Diagnosis based on whole slide images is established in human medical pathology, and the use of digital pathology in toxicologic pathology is increasing. However, there has not been broad adoption in toxicologic pathology, particularly in the context of regulatory studies, due to lack of precedence. To address this topic, as well as practical aspects, the European Society of Toxicologic Pathology coordinated an expert international workshop to assess current applications and challenges and outline a set of minimal requirements needed to gain future regulatory acceptance for the use of digital toxicologic pathology workflows in research and development, so that toxicologic pathologists can benefit from digital slide technology.Entities:
Keywords: digital pathology; good laboratory practice; nonclinical; regulatory; toxicologic pathology; validation; whole slide imaging
Year: 2020 PMID: 33297858 DOI: 10.1177/0192623320975841
Source DB: PubMed Journal: Toxicol Pathol ISSN: 0192-6233 Impact factor: 1.902